KERX on the move after the Q. Smaller loss than expected. More cash. Should be enough to finish testing. Phase III nearing completion.This could be a triple easy on good test results.
One day at a time
(0)
(0)
Keryx Biopharmaceuticals Inc. (KERX) Stock Research Links